Nanologica AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Nanologica AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11154
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nanologica AB (Nanologica) develops nanoporous silica specializing in materials
technology for clinical and chromatography applications. The company’s proprietary technology NLAB Saga, a nanoporous silica media well-adapted for chromatography is used in analytical columns and for bulk manufacturing applications. Its NLAB Silica technology is used for improved delivery of active pharmaceutical ingredients (APIs) in oral dosage forms. Nanologica’s technology loads the pores in the particles with drug substance and then compresses the particles into tablets that are used for treating spinal injuries and the autoimmune disease amyotrophic lateral sclerosis. It works in collaboration with other research institutions such as Stockholm University and Angstrom Laboratories at Uppsala University. Nanologica is headquartered in Sodertalje, Sweden.

Nanologica AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nanologica AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nanologica AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nanologica AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nanologica AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nanologica AB, Medical Devices Deals, 2012 to YTD 2018 9
Nanologica AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Nanologica AB, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Nanologica Enters into R&D Partnership 11
Nanolek Enters Into Agreement With Nanologica To Develop Drugs 12
Licensing Agreements 13
INIM Pharma Enters into Licensing Agreement with Nanologica 13
Nanologica Enters Licensing Agreement with Alcyone Lifesciences 14
Equity Offering 15
Nanologica Raises USD5.8 Million in Rights Offering of Shares 15
Sigrid Therapeutics Spins Out from Nanologica 16
Nanologica AB – Key Competitors 17
Nanologica AB – Key Employees 18
Nanologica AB – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Product News 20
Mar 31, 2017: Nanologica study published in Nanomedicine 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Nanologica AB, Pharmaceuticals & Healthcare, Key Facts 2
Nanologica AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nanologica AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nanologica AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nanologica AB, Deals By Therapy Area, 2012 to YTD 2018 8
Nanologica AB, Medical Devices Deals, 2012 to YTD 2018 9
Nanologica AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Nanologica Enters into R&D Partnership 11
Nanolek Enters Into Agreement With Nanologica To Develop Drugs 12
INIM Pharma Enters into Licensing Agreement with Nanologica 13
Nanologica Enters Licensing Agreement with Alcyone Lifesciences 14
Nanologica Raises USD5.8 Million in Rights Offering of Shares 15
Sigrid Therapeutics Spins Out from Nanologica 16
Nanologica AB, Key Competitors 17
Nanologica AB, Key Employees 18

List of Figures
Nanologica AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Nanologica AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Nanologica AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Nanologica AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Nanologica AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nanologica AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Nanologica AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nanologica AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nanologica AB, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Nanologica AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Invicta Holdings Limited:企業の戦略・SWOT・財務分析
    Invicta Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Invicta Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Antilles Oil and Gas NL (AVD):石油・ガス:M&Aディール及び事業提携情報
    Summary Antilles Oil and Gas NL (Antilles) is an upstream oil and gas company that carries out the acquisition and exploration of petroleum and gas properties. The company acquires underperforming assets and re-evaluates to identify untapped recoverable reserves. The company’s operates an exploratio …
  • Merafe Resources Ltd
    Merafe Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Merafe Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • PNC Wealth Management:企業の戦略・SWOT・財務情報
    PNC Wealth Management - Strategy, SWOT and Corporate Finance Report Summary PNC Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Boehringer Ingelheim GmbH-医療機器分野:企業M&A・提携分析
    Summary Boehringer Ingelheim GmbH (Boehringer), a subsidiary of C. H. Boehringer Sohn AG & Co KG is a pharmaceutical company, which carries out research, development, manufacture and sale of pharmaceuticals. The company offers a wide range of products including prescription medicines, consumer healt …
  • International Drug Development Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary International Drug Development Institute (IDDI) is a healthcare institute that offers clinical data collection, analysis, trial design and trial reporting services. The institute offers biostatistical services and eClinical services and risk-based monitoring programs. Its biostatistical serv …
  • Asarina Pharma AB-製薬・医療分野:企業M&A・提携分析
    Summary Asarina Pharma AB (Asarina Pharma), formerly Umecrine Mood AB, a subsidiary of Umecrine AB is a drug development company that concentrates on the discovery, development and commercialization of novel treatments for women suffering from premenstrual dysphoric disorder and other menstrual cycl …
  • Enel SpA (ENEL)-石油・ガス分野:企業M&A・提携分析
    Summary Enel S.p.A. (Enel) is an energy group that produces, distributes and trades electricity and natural gas. The group generates electricity using diverse sources of energy such as nuclear, renewables, oil and gas turbine, coal and gas combined cycle. It also focuses on digitizing electricity gr …
  • Guizhou Space Appliance Co., Ltd.:企業の戦略・SWOT・財務分析
    Guizhou Space Appliance Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Guizhou Space Appliance Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Bon Secours Health System Inc:企業の戦略的SWOT分析
    Bon Secours Health System Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Genera Biosystems Ltd (GBI)-医療機器分野:企業M&A・提携分析
    Summary Genera Biosystems Ltd (GBL) is a developer and commercializer of multiplexed molecular diagnostic testing products. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pat …
  • Bayerische Motoren Werke AG (BMW):企業の財務・戦略的SWOT分析
    Bayerische Motoren Werke AG (BMW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • LG Electronics, Inc.:企業の戦略・SWOT・財務情報
    LG Electronics, Inc. - Strategy, SWOT and Corporate Finance Report Summary LG Electronics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Lowe’s Companies, Inc.:戦略・SWOT・企業財務分析
    Lowe's Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Lowe's Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Acxiom Corporation (ACXM):企業の財務・戦略的SWOT分析
    Acxiom Corporation (ACXM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • GrafTech International Ltd:企業の戦略・SWOT・財務分析
    GrafTech International Ltd - Strategy, SWOT and Corporate Finance Report Summary GrafTech International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Indago Energy Ltd (INK):石油・ガス:M&Aディール及び事業提携情報
    Summary Indago Energy Ltd (Indago), formerly Pryme Energy Ltd is a provider of specialist oil and gas production chemicals. The company offers acquisition, up-gradation, exploration and production services to onshore oil and natural gas. It holds interests in the Newkirk project located in Kay Count …
  • Stena AB:企業の戦略的SWOT分析
    Stena AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Lincoln National Corporation:企業の戦略・SWOT・財務分析
    Lincoln National Corporation - Strategy, SWOT and Corporate Finance Report Summary Lincoln National Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • CorMedix Inc (CRMD):製薬・医療:M&Aディール及び事業提携情報
    Summary CorMedix Inc (CorMedix) is a commercial-stage pharmaceutical company that develops and commercializes therapeutic products for prevention and treatment of cardiac, renal and infectious diseases. The company offers neutrolin, a non-antibiotic anti-infective developed as a preventative solutio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆